STOCK TITAN

Bayview Acquisition trading suspended over June 19 deadline

Bayview says OTC trading may be very limited and gives no assurance that quotations or trading volume will support an efficient market.

(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Bayview Acquisition Corp. (BAYA) reported that Nasdaq’s Listing and Hearing Review Council affirmed the decision setting June 19, 2026 as the deadline to complete its business combination with Oabay Inc., and the decision to suspend trading afterward. Nasdaq suspended trading in the company’s securities effective at the open on July 7, 2026, following the company’s failure to complete the combination by the deadline. Bayview had requested an extension through December 19, 2026, and appealed the Panel’s decision.

Bayview anticipates Nasdaq will file a Form 25-NSE to remove its securities from Nasdaq listing and registration. The company intends to list its Ordinary Shares and Rights on the OTC Markets under BAYA and BAYAR. A market maker filed a Form 211 with FINRA on September 16, 2026, to initiate public quotation of the Ordinary Shares on the OTC Pink Market. Bayview cautioned that trading could be very limited and said it cannot assure that OTC trading or broker-dealer quotes will continue, or that volume will support an efficient market.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

How the balance works

Positive

  • None.

Negative

  • Major pointNasdaq suspension decision affirmed on September 22, 2026.

Insights

Analyzing...

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Business-combination deadline June 19, 2026 Deadline to complete the business combination with Oabay Inc.
Nasdaq trading suspension Effective July 7, 2026 Trading suspended from the open.
Requested extension deadline December 19, 2026 Date requested for an extension of the business-combination deadline.
Form 211 filing date September 16, 2026 Market maker filing to initiate public quotation of Ordinary Shares on the OTC Pink Market.
Ordinary Shares per unit 1 ordinary share Each unit consists of one ordinary share and one right.
Right entitlement One-tenth of one ordinary share Each right entitles its holder to one-tenth of one ordinary share.
Form 25-NSE regulatory
"file a Form 25-NSE with the SEC"
Form 25‑NSE is an official filing used to notify the stock exchange that a company’s securities are being removed from trading on that exchange, similar to handing in a key when a shop closes. Investors care because removal ends public trading on that venue, often cutting liquidity and making it harder to buy or sell shares, which can affect a stock’s price and how quickly investors can access cash or exit positions.
Form 211 regulatory
"filed a Form 211 with The Financial Industry Regulatory Authority"
Form 211 is the filing a broker-dealer submits to FINRA that provides the background, financial, and disclosure materials required under SEC Rule 15c2-11 before the dealer may publish or resume public quotations for a thinly traded or over-the-counter (OTC) security. It acts like an application that lets market makers show a bid and ask for a stock, so its acceptance affects whether and when a security becomes quoteable and thus how easily investors can buy or sell it.
OTC Pink Market market
"public quotation for the Company’s Ordinary Shares on the OTC Pink Market"
The OTC Pink Market is a segment of over-the-counter trading where shares of companies that do not meet formal exchange listing rules are bought and sold. It matters to investors because these stocks usually have little public information, low trading volume, and higher risk of price swings or fraud — like buying a rare item at a flea market where seller disclosure and return rules are minimal, so potential reward comes with greater uncertainty.
business combination financial
"complete its business combination with Oabay"
A business combination happens when two or more companies join together to operate as one, like two friends merging their teams into a single group. This is important because it can change how companies grow, compete, and make money, often making them bigger and more powerful in the market.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did Nasdaq suspend BAYA trading?

Nasdaq’s Hearings Panel determined to delist the securities because Bayview had not completed its business combination with Oabay Inc. on or before June 19, 2026. Nasdaq suspended trading effective at the open on July 7, 2026, and the Listing and Hearing Review Council affirmed the decisions on September 22, 2026.

Will BAYA trade on the OTC Markets?

Bayview intends to list its Ordinary Shares and Rights on the OTC Markets as BAYA and BAYAR. A market maker filed a Form 211 with FINRA on September 16, 2026, to initiate a public quotation for the Ordinary Shares on the OTC Pink Market. Bayview cannot assure that trading or broker-dealer quotes will continue.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001969475 0001969475 2026-09-22 2026-09-22 0001969475 BAYA:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember 2026-09-22 2026-09-22 0001969475 BAYA:OrdinarySharesParValue0.0001PerShareMember 2026-09-22 2026-09-22 0001969475 BAYA:RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember 2026-09-22 2026-09-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

current report
pursuant to section 13 or 15(D)
of the securities exchange act of 1934

 

Date of Report (Date of earliest event reported): September 22, 2026

 

 

 

Bayview Acquisition Corp

(Exact name of registrant as specified in its charter)

 

 

 

Cayman Islands   001-41890   N/A
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification Number)

 

420 Lexington Ave, Suite 2446

New York, NY 10170

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code (347) 627-0058

 

Not Applicable
(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one ordinary share and one right   BAYAU   The Nasdaq Stock Market LLC
Ordinary Shares, par value $0.0001 per share   BAYA   The Nasdaq Stock Market LLC
Rights, each right entitling the holder thereof to one-tenth of one ordinary share   BAYAR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

 

 

 

 

 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

As previously disclosed, on July 2, 2026, Bayview Acquisition Corp., a Cayman Islands exempted company (the “Company”) received a written notice from the Hearings Panel (the “Panel”) of Nasdaq stating that the Panel had determined to delist the Company’s securities from Nasdaq due to the Company’s failure to complete its business combination with Oabay Inc., a Cayman Islands exempted company limited by shares (“Oabay”) on or before June 19, 2026. Accordingly, the Panel suspended trading of the Company’s securities from Nasdaq, effective as of the open of trading on July 7, 2026. On July 17, 2026, the Company submitted a written Request for Review of Hearings Panel Decision and requested that Nasdaq grant a limited extension of the business combination deadline to December 19, 2026. Nasdaq confirmed receipt of the request on July 20, 2026, and on July 31, 2026, the Company submitted a Memorandum Appealing Hearings Panel Decision to Nasdaq in support of the request.

 

On September 22, 2026, the Company received two written notices from the Listing and Hearing Review Council (the “Council”) of Nasdaq stating that the Council has affirmed the Panel’s decisions to (a) set the June 19, 2026 deadline for the Company to complete its business combination with Oabay, and (b) thereafter, suspend the trading of the Company’s securities. The Company anticipates that Nasdaq will file a Form 25-NSE with the SEC, which will remove the Company’s securities from listing and registration on Nasdaq.

 

The Company intends to list its Ordinary Shares and Rights on the OTC Markets under the tickers “BAYA” and “BAYAR” respectively. On September 16, 2026, the Company’s market maker filed a Form 211 with The Financial Industry Regulatory Authority (FINRA), to initiate a public quotation for the Company’s Ordinary Shares on the OTC Pink Market. There may be a very limited market in which the Company’s securities are traded, and the trading price of the Company’s securities may be adversely affected. The Company can provide no assurance that its securities will trade on this market, whether broker-dealers will continue to provide public quotes of its securities on this market, or whether the trading volume of its securities will be sufficient to provide for an efficient trading market for existing and potential holders of its securities.

 

Forward-Looking Statements

 

This Current Report on Form 8-K may include “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as “believes,” “expects,” “intends,” “plans,” “estimates,” “assumes,” “may,” “should,” “will,” “seeks,” or other similar expressions. Such statements are subject to certain risks and uncertainties that may cause the Company’s actual results to differ from the expectations expressed in the forward-looking statements. There can be no assurance that the Company will achieve such expectations. The forward-looking statements contained in this report speak only as of the date of this report and the Company undertakes no obligation to publicly update any forward-looking statements to reflect changes in information, events or circumstances after the date of this report, unless required by law.

 

 

 

 

Item 9.01. Financial Statements and Exhibits

 

(d) Exhibits.

 

The Exhibit Index is incorporated by reference herein.

 

EXHIBIT INDEX

 

Exhibit No.   Description
104   Cover Page Interactive Data File (embedded with the Inline XBRL document).

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BAYVIEW ACQUISITION CORP
     
Date: September 28, 2026 By: /s/ Xin Wang
  Name: Xin Wang
  Title: Chief Executive Officer

 

 

Filing Exhibits & Attachments

4 documents

Keep reading